cp wire

CP Wire Articles

Exelixis and Invenra Partner to Develop Novel Biologics for Cancer Treatment
  • Companies will partner to advance multispecific antibodies in up to seven discrete projects, including one program against an undisclosed target currently in lead selection
  • Invenra... read more
Wed, 05/2/18 - 08:46 pm
Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe

Herzuma, biosimilar trastuzumab, is now available in Europe, with the product now launched in both the UK and Germany and further launches across European countries anticipated in the coming... read more

Wed, 05/2/18 - 08:12 pm
Bavarian Nordic Receives Orphan Drug Designation for BN-Brachyury for the Treatment of Rare Spinal Cancer
  • Phase I trials indicated BN-Brachyury is well tolerated
  • Initiating phase 2 study in patients with metastatic chordoma
  • Also has the potential to treat: triple negative breast... read more
Wed, 05/2/18 - 01:20 pm
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia


Kura Oncology, Inc. (Nasdaq:KURA)  announced on 5/2/18 that the U.S. Patent and Trademark Office (USPTO) has issued a new patent protecting the company's lead product candidate, tipifarnib. U.... read more

Wed, 05/2/18 - 10:01 am
Cirius Therapeutics Completes Enrollment in Phase 2b EMMINENCE Trial in NASH

Having recently completed a series A financing round of up to $40 million, Cirius Therapeutics announced on 5/2/2018 that it has reached its enrollment target in its Phase 2b EMMINENCE trial for... read more

Wed, 05/2/18 - 09:22 am

Pages